The Wall Street Journal's Health Blog recently had an item that suggests that drug companies' use of ghostwriters to promote positive findings and to not ask tough questions is alive and well.
Posted by schwitz at December 4, 2007 07:44 AM | TrackBackI couldn't agree more - Big Pharma is at it again!
Busy with R&D (Research & Development) Big Pharma lacks in the area of clinical trials, but excels in "positive findings".
At the end of the day it's all about money!
Posted by: William Hill at December 17, 2007 10:52 PM